HUP0203959A2 - New bispidine compounds useful in the treatment of cardiac arrhythmias, process for their preparation and pharmaceutical compositions containing them - Google Patents
New bispidine compounds useful in the treatment of cardiac arrhythmias, process for their preparation and pharmaceutical compositions containing themInfo
- Publication number
- HUP0203959A2 HUP0203959A2 HU0203959A HUP0203959A HUP0203959A2 HU P0203959 A2 HUP0203959 A2 HU P0203959A2 HU 0203959 A HU0203959 A HU 0203959A HU P0203959 A HUP0203959 A HU P0203959A HU P0203959 A2 HUP0203959 A2 HU P0203959A2
- Authority
- HU
- Hungary
- Prior art keywords
- hydrogen atom
- treatment
- optionally substituted
- preparation
- pharmaceutical compositions
- Prior art date
Links
- 206010003119 arrhythmia Diseases 0.000 title abstract 2
- PTPQJKANBKHDPM-UHFFFAOYSA-N 3,7-diazabicyclo[3.3.1]nonane Chemical class C1NCC2CNCC1C2 PTPQJKANBKHDPM-UHFFFAOYSA-N 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 6
- 125000000547 substituted alkyl group Chemical group 0.000 abstract 4
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 125000005156 substituted alkylene group Chemical group 0.000 abstract 2
- 206010003130 Arrhythmia supraventricular Diseases 0.000 abstract 1
- 206010047281 Ventricular arrhythmia Diseases 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 230000006793 arrhythmia Effects 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 230000001746 atrial effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
A találmány tárgyát az általános képletű vegyületek - ahol R1 és R2egymástól függetlenül hidrogénatom vagy adott esetben szubsztituáltalkilcsoport; R3 hidrogénatom, alkilcsoport; R4 hidrogénatom vagyadott esetben szubsztituált alkil- és alkoxicsoport; R5 hidrogén-,halogénatom, alkilcsoport; R6 hidrogénatom vagy adott esetbenszubsztituált alkilcsoport; R7 adott esetben szubsztituált alkil-, aril- vagy Het- csoport; R41, R42, R43, R44, R45, R46 egymástól függetlenül hidrogénatomvagy alkilcsoport; A egyes kötés vagy adott esetbenszubsztituált alkiléncsoport; B egyes kötés vagy adott esetben szubsztituáltalkiléncsoport - és gyógyszerészetileg elfogadható származékaik ésezeket tartalmazó, aritmiák, különösen az atriális és ventrikulárisaritmiák megelőzésében és kezelésében alkalmazhatógyógyszerkészítmények képezik. ÓThe subject of the invention is the compounds of the general formula - where R1 and R2 independently of each other are a hydrogen atom or optionally a substituted alkyl group; R3 hydrogen atom, alkyl group; R4 is a hydrogen atom or an optionally substituted alkyl and alkoxy group; R5 is a hydrogen atom, a halogen atom, an alkyl group; R6 is a hydrogen atom or an optionally substituted alkyl group; R7 is an optionally substituted alkyl, aryl or Het group; R41, R42, R43, R44, R45, R46 independently of each other are a hydrogen atom or an alkyl group; The single bond or optionally substituted alkylene group; A single bond or optionally substituted alkylene group - and their pharmaceutically acceptable derivatives are used in the prevention and treatment of arrhythmias, especially atrial and ventricular arrhythmias. HE
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9902268A SE9902268D0 (en) | 1999-06-16 | 1999-06-16 | Pharmaceutically active compounds |
PCT/SE2000/001254 WO2000077000A1 (en) | 1999-06-16 | 2000-06-15 | New bispidine compounds useful in the treatment of cardiac arrhythmias |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0203959A2 true HUP0203959A2 (en) | 2003-03-28 |
HUP0203959A3 HUP0203959A3 (en) | 2003-04-28 |
Family
ID=20416100
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0203959A HUP0203959A3 (en) | 1999-06-16 | 2000-06-15 | New bispidine compounds useful in the treatment of cardiac arrhythmias, process for their preparation and pharmaceutical compositions containing them |
Country Status (24)
Country | Link |
---|---|
EP (1) | EP1192157A1 (en) |
JP (1) | JP2003502329A (en) |
KR (1) | KR20020010713A (en) |
CN (1) | CN1144805C (en) |
AR (1) | AR024577A1 (en) |
AU (1) | AU761576B2 (en) |
BR (1) | BR0011660A (en) |
CA (1) | CA2375841A1 (en) |
CZ (1) | CZ20014495A3 (en) |
EE (1) | EE200100675A (en) |
HK (1) | HK1045520A1 (en) |
HU (1) | HUP0203959A3 (en) |
IL (1) | IL146754A0 (en) |
IS (1) | IS6201A (en) |
MX (1) | MXPA01012919A (en) |
NO (1) | NO20016117L (en) |
NZ (1) | NZ516013A (en) |
PL (1) | PL354032A1 (en) |
RU (1) | RU2250903C2 (en) |
SE (1) | SE9902268D0 (en) |
SK (1) | SK18272001A3 (en) |
TR (1) | TR200103663T2 (en) |
WO (1) | WO2000077000A1 (en) |
ZA (1) | ZA200109796B (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR030302A1 (en) * | 2000-07-07 | 2003-08-20 | Astrazeneca Ab | BISPIDINE COMPOUNDS, PHARMACEUTICAL FORMULATION, USE FOR THE MANUFACTURE OF MEDICINES, PROCESS FOR THE PREPARATION OF THESE INTERMEDIATE COMPOUNDS AND COMPOUNDS |
SE0101327D0 (en) | 2001-04-12 | 2001-04-12 | Astrazeneca Ab | New crystalline forms |
TWI499418B (en) * | 2009-05-21 | 2015-09-11 | Nerviano Medical Sciences Srl | Isoquinolin-1(2h)-one derivatives |
US9169198B2 (en) * | 2011-07-08 | 2015-10-27 | Bayer Intellectual Property Gmbh | Method for the production of 2-amino-5-cyano-N,3-dimethylbenzamide |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT88381B (en) * | 1987-09-09 | 1995-07-06 | Kali Chemie Pharma Gmbh | PROCESS FOR THE PREPARATION OF NEW COMPOUNDS 3,7-DIAZABICYCLO (3,3,1) NONANO, AND OF PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS |
DE3732094A1 (en) * | 1987-09-24 | 1989-04-06 | Basf Ag | BISPID DERIVATIVES AS CLASS III ANTIARRHYTHMICS |
US5110933A (en) * | 1989-11-13 | 1992-05-05 | Board Of Regents Of Oklahoma State University | Salts of 3-azabicyclo[3.3.1]nonanes as antiarrhythmic agents, and precursors thereof |
US5468858A (en) * | 1993-10-28 | 1995-11-21 | The Board Of Regents Of Oklahoma State University Physical Sciences | N-alkyl and n-acyl derivatives of 3,7-diazabicyclo-[3.3.1]nonanes and selected salts thereof as multi-class antiarrhythmic agents |
SE9704709D0 (en) * | 1997-12-17 | 1997-12-17 | Astra Ab | Pharmaceutically active compounds |
-
1999
- 1999-06-16 SE SE9902268A patent/SE9902268D0/en unknown
-
2000
- 2000-06-15 JP JP2001503858A patent/JP2003502329A/en active Pending
- 2000-06-15 RU RU2001132563/04A patent/RU2250903C2/en not_active IP Right Cessation
- 2000-06-15 NZ NZ516013A patent/NZ516013A/en unknown
- 2000-06-15 BR BR0011660-2A patent/BR0011660A/en not_active IP Right Cessation
- 2000-06-15 CA CA002375841A patent/CA2375841A1/en not_active Abandoned
- 2000-06-15 MX MXPA01012919A patent/MXPA01012919A/en unknown
- 2000-06-15 CN CNB008116962A patent/CN1144805C/en not_active Expired - Fee Related
- 2000-06-15 CZ CZ20014495A patent/CZ20014495A3/en unknown
- 2000-06-15 WO PCT/SE2000/001254 patent/WO2000077000A1/en not_active Application Discontinuation
- 2000-06-15 IL IL14675400A patent/IL146754A0/en unknown
- 2000-06-15 AU AU60324/00A patent/AU761576B2/en not_active Ceased
- 2000-06-15 KR KR1020017016168A patent/KR20020010713A/en not_active Application Discontinuation
- 2000-06-15 EP EP00946589A patent/EP1192157A1/en not_active Withdrawn
- 2000-06-15 SK SK1827-2001A patent/SK18272001A3/en unknown
- 2000-06-15 PL PL00354032A patent/PL354032A1/en not_active Application Discontinuation
- 2000-06-15 TR TR2001/03663T patent/TR200103663T2/en unknown
- 2000-06-15 EE EEP200100675A patent/EE200100675A/en unknown
- 2000-06-15 HU HU0203959A patent/HUP0203959A3/en unknown
- 2000-06-16 AR ARP000103015A patent/AR024577A1/en not_active Application Discontinuation
-
2001
- 2001-11-28 ZA ZA200109796A patent/ZA200109796B/en unknown
- 2001-12-14 NO NO20016117A patent/NO20016117L/en not_active Application Discontinuation
- 2001-12-14 IS IS6201A patent/IS6201A/en unknown
-
2002
- 2002-09-27 HK HK02107165.2A patent/HK1045520A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
RU2250903C2 (en) | 2005-04-27 |
WO2000077000A9 (en) | 2003-06-19 |
JP2003502329A (en) | 2003-01-21 |
AU6032400A (en) | 2001-01-02 |
SE9902268D0 (en) | 1999-06-16 |
SK18272001A3 (en) | 2002-12-03 |
AU761576B2 (en) | 2003-06-05 |
CN1370167A (en) | 2002-09-18 |
ZA200109796B (en) | 2003-02-28 |
NZ516013A (en) | 2003-06-30 |
PL354032A1 (en) | 2003-12-15 |
NO20016117L (en) | 2002-02-15 |
HUP0203959A3 (en) | 2003-04-28 |
CN1144805C (en) | 2004-04-07 |
EP1192157A1 (en) | 2002-04-03 |
CA2375841A1 (en) | 2000-12-21 |
CZ20014495A3 (en) | 2002-05-15 |
TR200103663T2 (en) | 2002-05-21 |
NO20016117D0 (en) | 2001-12-14 |
MXPA01012919A (en) | 2002-07-30 |
KR20020010713A (en) | 2002-02-04 |
IS6201A (en) | 2001-12-14 |
EE200100675A (en) | 2003-02-17 |
AR024577A1 (en) | 2002-10-16 |
BR0011660A (en) | 2002-03-26 |
HK1045520A1 (en) | 2002-11-29 |
IL146754A0 (en) | 2002-07-25 |
WO2000077000A1 (en) | 2000-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0202593A2 (en) | Benzophenones as inhibitors of reverse transcriptase | |
HUP0102471A2 (en) | 4-benzyl piperidine alkylsulfoxide heterocycles and their use as subtype-selective nmda receptor antagonists and pharmaceutical compositions containing them | |
HUP0202263A2 (en) | Benzimidazole, indole and imidazo-pyridine derivatives and pharmaceutical compositions containing them | |
HUP0002347A2 (en) | Use of hydantoin, oxazole and pyrrole derivatives for the preparation of pharmaceutical compositions inflammatory disease treating | |
HUP0301690A2 (en) | Synergistic methods and compositions for treating cancer | |
SE9902987D0 (en) | Novel compounds | |
NZ514981A (en) | Renin inhibitors | |
NO20060147L (en) | Benzimidazole derivatives, compositions containing them, their preparation and their use | |
HUP0400266A2 (en) | Pharmaceutical compositions containing imidazo[1,2-a]pyridine derivatives, and their use for the prophylaxis and treatment of herpes viral infections | |
AP1536A (en) | New oxabispidine compounds useful in the treatment of cardiac arrhythmias. | |
NO20060146L (en) | Benzimidazole derivatives, compositions containing them, their preparation and their use | |
CA2370244A1 (en) | Piperidine derivatives | |
CA2280727A1 (en) | Bicyclic amino acids | |
NO20022124L (en) | Imidazopyridine derivatives as phosphodiesterase VII inhibitors | |
ATE233754T1 (en) | DIPHENYL-PIPERIDINE DERIVATIVES | |
CA2136553A1 (en) | 7-(2-aminoethyl)-Benzothiazolones | |
TR200102524T2 (en) | Dihetero-substituted metalloprotease inhibitors. | |
HUP0401596A2 (en) | Cross-linked glycopeptide-cephalosporin antibiotics and pharmaceutical compositions containing them | |
WO2003082861A3 (en) | Morpholinyl-urea derivatives for use of the treatment of inflammatory diseases | |
MY133785A (en) | Azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias | |
RU2010116779A (en) | INDAZOLACRYLIC ACID DERIVATIVE | |
HUP0203959A2 (en) | New bispidine compounds useful in the treatment of cardiac arrhythmias, process for their preparation and pharmaceutical compositions containing them | |
DE60318874D1 (en) | Pyrazolderivate | |
SE9902551D0 (en) | Novel compounds | |
NO20022123L (en) | Oxoxazole derivatives for use as inhibitors of phosphodiesterase VII |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD9A | Lapse of provisional protection due to non-payment of fees |